Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 24.23% is 248% above its 5-year average of -16.34%, near the high end of its 5-year range (-180.11%–90.10%).
63.20% above its 12-month average of 14.85%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 83.85%.
NET PROFIT MARGIN
24.23%
NET PROFIT MARGIN AVG TTM
14.85%
NET PROFIT MARGIN AVG 3Y
-12.94%
NET PROFIT MARGIN AVG 5Y
-16.34%
NET PROFIT MARGIN AVG 10Y
-18.77%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+63.20%
CURRENT VS 3Y AVG
+287.31%
CURRENT VS 5Y AVG
+248.32%
CURRENT VS 10Y AVG
+229.06%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 562 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
CareDx, Inc
Market Cap
$3.51B
Net Profit Margin
24.23%
TTM Avg
14.85%
3Y Avg
-12.94%
5Y Avg
-16.34%
Market Cap
$3.49B
Net Profit Margin
-74.75%
TTM Avg
-1986.54%
3Y Avg
-1142.83%
5Y Avg
-820.99%
Market Cap
$3.60B
Net Profit Margin
-1.69%
TTM Avg
-12.55%
3Y Avg
-19.61%
5Y Avg
-21.06%
Market Cap
$3.40B
Net Profit Margin
33.42%
TTM Avg
30.07%
3Y Avg
2.48%
5Y Avg
-14.75%
Market Cap
$3.98B
Net Profit Margin
1.39%
TTM Avg
-2.46%
3Y Avg
-2.37%
5Y Avg
0.86%
Market Cap
$3.05B
Net Profit Margin
-14191.20%
TTM Avg
0.00%
3Y Avg
-86.13%
5Y Avg
-153.41%
Market Cap
$3.09B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.04B
Net Profit Margin
6.15%
TTM Avg
-37.77%
3Y Avg
-2241.27%
5Y Avg
-1494.18%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CareDx, Inc (CDNA) | $3.51B | 24.23% | 14.85% | -12.94% | -16.34% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.49B | -74.75% | -1986.54% | -1142.83% | -820.99% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.60B | -1.69% | -12.55% | -19.61% | -21.06% |
| Celcuity Inc. (CELC)vs › | $3.45B | 0.00% | 0.00% | 0.00% | 0.00% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.40B | 33.42% | 30.07% | 2.48% | -14.75% |
| ICU Medical, Inc. (ICUI)vs › | $3.98B | 1.39% | -2.46% | -2.37% | 0.86% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.05B | -14191.20% | 0.00% | -86.13% | -153.41% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.09B | 0.00% | 0.00% | 0.00% | 0.00% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.04B | 6.15% | -37.77% | -2241.27% | -1494.18% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.01B | 0.00% | -172.68% | -306.20% | -1288.24% |
Operating Margin
-0.9%
Net Profit Margin
24.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 83.85% |
| 2026-03-31 | 2.39% |
| 2025-12-31 | -3.79% |
| 2025-09-30 | 1.67% |
| 2025-06-30 | -9.88% |
| 2025-03-31 | -12.23% |
| 2024-12-31 | 90.10% |
| 2024-09-30 | -8.94% |
| 2024-06-30 | -5.01% |
| 2024-03-31 | -23.12% |
| 2023-12-31 | -180.11% |
| 2023-09-30 | -34.95% |
| 2023-06-30 | -35.49% |
| 2023-03-31 | -30.74% |
| 2022-12-31 | -22.25% |
| 2022-09-30 | -21.34% |
| 2022-06-30 | -26.91% |
| 2022-03-31 | -24.74% |
| 2021-12-31 | -20.39% |
| 2021-09-30 | -15.74% |
| 2021-06-30 | -2.60% |
| 2021-03-31 | -1.02% |
| 2020-12-31 | -5.99% |
| 2020-09-30 | -5.28% |
| 2020-06-30 | -15.69% |
| 2020-03-31 | -15.17% |
| 2019-12-31 | -13.34% |
| 2019-09-30 | -5.36% |
| 2019-06-30 | -24.95% |
| 2019-03-31 | -28.99% |
| 2018-12-31 | -15.97% |
| 2018-09-30 | -94.27% |
| 2018-06-30 | -78.90% |
| 2018-03-31 | -63.82% |
| 2017-12-31 | -253.31% |
| 2017-09-30 | -117.04% |
| 2017-06-30 | -32.94% |
| 2017-03-31 | -48.01% |
| 2016-12-31 | -142.54% |
| 2016-09-30 | -30.17% |
| 2016-06-30 | -96.52% |
| 2016-03-31 | -148.61% |
| 2015-12-31 | -71.63% |
| 2015-09-30 | -48.79% |
| 2015-06-30 | -44.68% |
| 2015-03-31 | -31.49% |
| 2014-12-31 | -0.06% |
| 2014-09-30 | 18.23% |
| 2014-06-30 | 12.94% |
| 2014-03-31 | -22.01% |
| 2013-12-31 | -9.60% |
| 2013-09-30 | -14.30% |
| 2013-06-30 | -14.70% |
| 2013-03-31 | -27.06% |